Sector Gamma AS’s Teva Pharmaceuticals TEVA Stock Holding History

Sector Gamma AS’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-262,000	Closed	-$15.5M	–	25
2015 Q2	$15.5M	Buy	262,000 +78,000	+42%	+$4.81M	3.95%	12
2015 Q1	$11.5M	Buy	184,000 +27,700	+18%	+$1.61M	3.03%	14
2014 Q4	$8.99M	Sell	156,300 -184,300	-54%	-$10.3M	2%	22
2014 Q3	$18.3M	Buy	340,600 +6,000	+2%	+$318K	4.28%	5
2014 Q2	$17.5M	Sell	334,600 -55,400	-14%	-$2.83M	4.15%	8
2014 Q1	$20.6M	Buy	390,000 +92,300	+31%	+$4.27M	4.94%	6
2013 Q4	$11.9M	Buy	297,700 +34,400	+13%	+$1.35M	3.22%	10
2013 Q3	$9.95M	Sell	263,300 -75,700	-22%	-$2.95M	2.55%	16
2013 Q2	$13.3M	Buy	+339,000	New	+$13.2M	3.88%	8

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sector Gamma AS's TEVA Position: Q3 2015 in Review

Sector Gamma AS sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 262,000 shares — an estimated $15.5M sold.

Sector Gamma AS first reported a position in TEVA in Q2 2013 and held it in 9 quarters. The position peaked at $20.6M in Q1 2014. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Sector Gamma AS reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Sector Gamma AS sold 262,000 Teva Pharmaceuticals shares in Q3 2015, an estimated $15.5M.
Sector Gamma AS first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Sector Gamma AS's Teva Pharmaceuticals position peaked at $20.6M in Q1 2014.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Sector Gamma AS's 13F filing for Q3 2015, filed 16 Nov 2015.